Company Filing History:
1 out of 19 
1 out of 371 
1 out of 525 
Years Active: 2014
Title: The Innovative Contributions of Inventor Catherine To
Introduction
Catherine To is an accomplished inventor based in Bayswater North, Australia. With a compelling patent portfolio, she has made significant strides in the field of medical research, particularly in the treatment of solid tumors.
Latest Patents
Catherine holds a patent for "EphA3 antibodies for the treatment of solid tumors." This groundbreaking invention provides methods and compositions comprising anti-EphA3 antibodies aimed at tackling solid tumors, showcasing her commitment to enhancing cancer treatment options.
Career Highlights
Throughout her career, Catherine To has worked with prominent organizations, including Kalobios Pharmaceuticals, Inc. and Monash University. Her experience in these reputable institutions has not only bolstered her expertise but has also facilitated her innovative contributions to the medical field.
Collaborations
Catherine has collaborated with notable colleagues such as Martin Lackmann and Andrew Ewart Scott. These partnerships have likely fostered a creative environment, allowing for the exchange of ideas and advancements in research that can impact patient care.
Conclusion
Catherine To’s dedication to innovation and her contributions to the invention of EphA3 antibodies underscore her role as a pivotal figure in the ongoing battle against cancer. Her work continues to inspire future innovations and improvements in treatment methodologies for solid tumors.